This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Aging/ Geriatrics  • Men's Health  • Prostate Disease  • Oncology  • Prostate Cancer  • Alert me on articles by topic  Social Bookmarking   What's this?

Bridget M. Kuehn

JAMA. 2008;300(12):1403.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Men aged 75 years or older should not be screened for prostate cancer, and younger men and their physicians should carefully weigh the risks and benefits of such screening, according to a new recommendation from the US Preventive Services Task Force.

According to the recommendations, there is little to no benefit of treatment for prostate cancer detected by screening in those aged 75 years or older (US Preventive Services Task Force. Ann Intern Med. 2008;149[3]:185-191, http://www.ahrq.gov/clinic/uspstf/uspsprca.htm). In fact, few men aged 75 years or older are likely to have their life expectancy extended by such treatment, yet they may face such negative health consequences from treatment as erectile dysfunction, urinary incontinence, bowel dysfunction, and death. Additionally, many men who screen positive for prostate cancer face unnecessary anxiety because they may not develop symptoms within their lifetime.

The task force also concluded that there is inadequate . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?